Christopher M. Reid

Researcher Next ID · RN-033166

Researcher · Medicine

Curtin University

Perth, Australia

Accepting doctoral researchersFunding unknown

Works count: 1,448
Citation count: 32,958
H-index: 82
i10-index: 518

Research interests

Medicine

Acute Myocardial Infarction Research

Coronary Interventions and Diagnostics

Blood Pressure and Hypertension Studies

Cardiac, Anesthesia and Surgical Outcomes

Antiplatelet Therapy and Cardiovascular Diseases

Publications

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)02034-7
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(21)01921-8
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(21)00590-0
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1805819
Effect of Aspirin on Disability-free Survival in the Healthy Elderly
New England Journal of Medicine · 2018 · 10.1056/nejmoa1800722
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1803955
Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study
The Journals of Gerontology Series A · 2017 · https://doi.org/10.1093/gerona/glw342
Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)
Neurology · 2016 · https://doi.org/10.1212/wnl.0000000000002459
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1600176
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1600175
Development and validation of the E mergency D epartment A ssessment of C hest pain S core and 2 h accelerated diagnostic protocol
Emergency Medicine Australasia · 2014 · https://doi.org/10.1111/1742-6723.12164
Validation of High-Sensitivity Troponin I in a 2-Hour Diagnostic Strategy to Assess 30-Day Outcomes in Emergency Department Patients With Possible Acute Coronary Syndrome
Journal of the American College of Cardiology · 2013 · https://doi.org/10.1016/j.jacc.2013.02.078
2-Hour Accelerated Diagnostic Protocol to Assess Patients With Chest Pain Symptoms Using Contemporary Troponins as the Only Biomarker
Journal of the American College of Cardiology · 2012 · https://doi.org/10.1016/j.jacc.2012.02.035
A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly
New England Journal of Medicine · 2003 · https://doi.org/10.1056/nejmoa021716
Effect of sunlight and season on serotonin turnover in the brain
The Lancet · 2002 · https://doi.org/10.1016/s0140-6736(02)11737-5

Current projects

No projects listed.